Henry Schein (NASDAQ:HSIC) Price Target Lowered to $76.00 at JPMorgan Chase & Co.

Key Points

• JPMorgan Chase & Co. has lowered its price target for Henry Schein from $80.00 to $76.00, while maintaining an "overweight" rating on the stock.
• Other analysts have also adjusted their price targets, with Barrington Research lowering theirs to $78.00 and Piper Sandler to $77.00.
• Henry Schein's stock closed at $65.90 on the day of the report, showing a potential upside of 15.33% from the new price target.

Henry Schein (NASDAQ:HSIC - Get Free Report) had its target price decreased by equities research analysts at JPMorgan Chase & Co. from $80.00 to $76.00 in a report released on Thursday,Benzinga reports. The brokerage currently has an "overweight" rating on the stock. JPMorgan Chase & Co.'s target price would suggest a potential upside of 15.26% from the stock's previous close.

HSIC has been the subject of a number of other reports. Evercore ISI reduced their price objective on shares of Henry Schein from $78.00 to $70.00 and set an "in-line" rating for the company in a research report on Wednesday. Baird R W cut shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 14th. Stifel Nicolaus reissued a "hold" rating and issued a $75.00 target price (down previously from $80.00) on shares of Henry Schein in a research report on Friday, July 25th. UBS Group reduced their target price on shares of Henry Schein from $75.00 to $70.00 and set a "neutral" rating for the company in a research report on Wednesday. Finally, Leerink Partners set a $75.00 target price on shares of Henry Schein in a research report on Monday, July 14th. Nine equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $75.58.

Henry Schein Stock Performance

HSIC stock traded up $0.04 during midday trading on Thursday, reaching $65.94. 1,931,964 shares of the company were exchanged, compared to its average volume of 2,156,766. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.75. The business has a 50-day moving average price of $71.07 and a two-hundred day moving average price of $71.09. Henry Schein has a one year low of $60.56 and a one year high of $82.49. The firm has a market capitalization of $8.00 billion, a price-to-earnings ratio of 21.27, a price-to-earnings-growth ratio of 2.17 and a beta of 0.81.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%. The company had revenue of $3.24 billion for the quarter, compared to the consensus estimate of $3.22 billion. During the same period last year, the firm earned $1.23 earnings per share. The company's revenue for the quarter was up 3.3% compared to the same quarter last year. Equities research analysts forecast that Henry Schein will post 4.74 EPS for the current year.

Institutional Investors Weigh In On Henry Schein

Several institutional investors and hedge funds have recently bought and sold shares of the company. JPMorgan Chase & Co. lifted its position in Henry Schein by 6.5% during the first quarter. JPMorgan Chase & Co. now owns 6,373,036 shares of the company's stock worth $436,489,000 after purchasing an additional 390,399 shares during the period. Invesco Ltd. lifted its position in Henry Schein by 0.4% during the fourth quarter. Invesco Ltd. now owns 4,963,409 shares of the company's stock worth $343,468,000 after purchasing an additional 17,552 shares during the period. FMR LLC lifted its position in Henry Schein by 6.6% during the fourth quarter. FMR LLC now owns 3,498,033 shares of the company's stock worth $242,064,000 after purchasing an additional 217,143 shares during the period. Palestra Capital Management LLC bought a new position in shares of Henry Schein in the fourth quarter worth about $182,988,000. Finally, Fiduciary Management Inc. WI lifted its holdings in shares of Henry Schein by 7.2% in the fourth quarter. Fiduciary Management Inc. WI now owns 2,488,335 shares of the company's stock worth $172,193,000 after acquiring an additional 167,990 shares during the last quarter. Institutional investors own 96.62% of the company's stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.